Narcissus pseudonarcissus L. (Amaryllidaceae) bulb metabolite profiling and biological activities

Abstract

Various metabolomics approaches have greatly contributed to the study of natural products from medicinal plants. Among thousands of plant species, Narcissus pseudonarcissus L. (Amaryllidaceae) is reputed for its ornamental, industrial, and medicinal applications. This plant is also used traditionally for microbial infections, inflammations, skin complaints, and cancers. Long ago, N. pseudonarcissus has gained considerable research interest thanks to its diverse alkaloids that have been widely studied. However, the non-alkaloidal principles and different bioactivities of this plant were poorly deliberated in previous works. Therefore, this work evaluates the biological potential of N. pseudonarcissus bulbs′ total ethanol extract (TEE) and its derived fractions (I‒IV), along with exploring the overlooked non-alkaloidal metabolites of this amaryllid. Overall, GC‒MS-based analysis of the bulbs led to the identification of varied metabolites, e.g., long-chain alkyl amines, alkylbenzenes, long-chain hydrocarbons, fatty acid derivatives, and phenylpropanoids. Most of these phytochemicals are first characterized herein in either the genus Narcissus or the family Amaryllidaceae. Additionally, the acidic EtOAc fraction (II) exhibited the highest scavenging potential of the 2,2′-diphenyl-1-picrylhydrazyl radical and the greatest ferric reducing power, possibly due to its relatively higher contents of phenolics and flavonoids that were also estimated herein. On the other hand, the basic EtOAc fraction (III) exerted the maximum anti-proliferative actions against Caco-2 (colon) and Mcf-7 (breast) tumor cells, while all of the tested fractions were inactive against HepG-2 (liver) cancer cells. Finally, different N. pseudonarcissus fractions demonstrated varied inhibitory activities against a group of pathogenic bacteria and fungi. Among them, fractions II and III were further observed as good synergists with some standard antimicrobial agents, even against some resistant microbial strains. These data could support the reported use of N. pseudonarcissus in traditional medical systems and help widen its future phytochemical and biological prospection.